Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
about
Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4Cellular senescence and tumor suppressor gene p16Regulation of p16CDKN2 expression and its implications for cell immortalization and senescenceMN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in miceBiomarkers of head and neck cancer, tools or a gordian knot?Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b)Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.Cell cycle regulators and their abnormalities in breast cancer.Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.The effects of fucodian on senescence are controlled by the p16INK4a-pRb and p14Arf-p53 pathways in hepatocellular carcinoma and hepatic cell lines.The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts.Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis.Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin ERB maintains quiescence and prevents premature senescence through upregulation of DNMT1 in mesenchymal stromal cells.Signalling pathways in endometrial cancerDetection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation.pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma.Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivationHypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progressionAlteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformationHuman papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implicationsRepression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1Expression of cdk4 and p16 in Oral Lichen PlanusCdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblastsInvolvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients.Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistryInduction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation.Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer.Loss of functional pRB is not a ubiquitous feature of B-cell malignancies
P2860
Q24314643-530F7717-2687-4B11-B1D8-FBD723F6E73DQ24629853-2F2ACEF0-1D68-401B-9369-D82BB655B0EEQ24650807-B761ACED-C509-44F1-B1CC-4A0A4E66D70DQ24669642-54DA5199-F789-4304-811B-A91416EF129DQ26784289-2F9253BF-58E1-4F4D-A782-37DAF712B080Q28609756-5B7D568A-B56F-4507-8BCE-4E1F7E82C978Q31132352-7CE1B8EF-A416-4C00-BDCD-FA0476743B61Q33278623-09B52FD1-A6EE-4851-8CF0-E3A0F34BAB91Q33588357-5304F38A-ACD0-4536-A66E-FE49BDD73F89Q33822845-E982C39A-2FF9-4D07-8508-785EA08D2AC2Q33836515-3D720C83-94C3-47F3-82C3-7981C85551F9Q33889383-58255360-ADB4-46B4-A4AC-45DD5ADC6C9CQ33957508-C16DE6EE-CB54-4F51-ADFB-6CAD67B7747BQ33996518-DFC966FA-7D72-4F45-AB53-1D345388792FQ34011808-A0E37F6E-AAFE-4B6F-98D0-472F08D97A18Q34069083-70F733F6-27B5-4798-A860-5FFCD9E0ADC2Q34684301-918D68DD-9B17-41D4-A412-A209D7ADC145Q34721660-4CA44C17-2D98-425D-975E-B760FFE03F39Q35133570-94515409-F928-4FE9-93BE-E6EED677FE15Q35565308-EC95E271-6232-4AE6-8318-057090B634B3Q35586592-8781ED9E-AC65-47AF-92AD-59302BEA16C8Q35588555-7D50EAD3-8650-4265-92F0-114983C53E2AQ35753196-8967D8EA-EE85-48ED-8936-7ED4F5A55D52Q35764156-593EB89E-DFE6-4CC3-B3B5-DB885FD184C6Q35770139-D8EE597B-039D-423A-A24E-F3EDF85EC8B9Q35788039-BC173EF1-3C63-4A87-A979-0C4DB823CB00Q35791446-11719DCE-7EFF-49A2-B397-362D0743D672Q35854673-214B6F34-51E1-4CD2-8557-F4554AC5DF38Q35866493-A846FFB7-FCED-42FB-ABFF-61623DFBEB17Q35872212-FE2423F2-434E-4476-9800-FDC5B3C775E9Q35894500-4EA9DBAE-5813-493A-884D-B422430BCE62Q35919276-514162D4-C009-4886-941D-1B0B5DC35F2BQ35927191-E0968666-5668-49F7-9AAB-A755AE001592Q36138681-F6F461CE-F9FF-41E8-83EB-8324693B6AFAQ36190032-A7175C61-5E69-4D1C-B07B-E65EBBA759DCQ36292511-0EFDC469-6549-431D-BECC-22A7FEDF34AEQ36421683-928F1E7F-2C58-4960-8F03-05D6B38BF7C2Q36438383-F9E9938D-BBC3-4F3A-A2E8-D9D5168587C3Q36459831-E2BF173B-6D35-47B1-97DE-C899C23B8C4FQ36617740-362B6B15-DA12-4739-BEAF-48CF14B8FB6F
P2860
Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Transcriptional repression of ...... sceptibility gene product pRb.
@ast
Transcriptional repression of ...... sceptibility gene product pRb.
@en
Transcriptional repression of ...... sceptibility gene product pRb.
@nl
type
label
Transcriptional repression of ...... sceptibility gene product pRb.
@ast
Transcriptional repression of ...... sceptibility gene product pRb.
@en
Transcriptional repression of ...... sceptibility gene product pRb.
@nl
prefLabel
Transcriptional repression of ...... sceptibility gene product pRb.
@ast
Transcriptional repression of ...... sceptibility gene product pRb.
@en
Transcriptional repression of ...... sceptibility gene product pRb.
@nl
P2093
P1433
P1476
Transcriptional repression of ...... usceptibility gene product pRb
@en
P2093
P304
P407
P577
1994-12-01T00:00:00Z